Sherwin-Williams Co. (0L5V)
London Exchange · UK · prices in USD · close of 21 Oct 2026
Key indicators
| Last close | USD 337.63 |
|---|---|
| 52-week range | 288.95 – 377.31 |
| Return, 1 month / 3 months | +2.8% / +9.3% |
| Return, 1 year / 3 years | +2.4% / +36.1% |
| Trend | Uptrend |
| RSI (14) | 60 |
| Volatility (1 year) | 27.6% |
| Worst drawdown (1 year) | -20.6% |
| Average daily value traded | 0.31M USD |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Sherwin-Williams is a paint and coatings company based in Cleveland, Ohio. It makes and sells paints, stains, varnishes and related supplies for homes, commercial buildings and industrial uses, and it also supplies coatings for automotive and manufacturing customers. Its products reach customers through its own paint stores, where contractors and do-it-yourself buyers shop, and through other retailers and distributors. The company sells under several brand names and serves both professional and household customers in markets around the world.
On this site Sherwin-Williams Co. appears as a stock on the London Exchange (UK), code 0L5V, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Sherwin-Williams Co. (0L5V) trades on the London Exchange in UK. It last closed at USD 337.63 on 21 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,497 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 2.4% and over the last three months it rose 9.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.6% | ||
| From 52-week high | -8.4% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 9.3% | ||
| 6-month return | 1.5% | ||
| 12-month return, skipping the last month | -0.4% | ||
| Stability (higher is calmer) | 70 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.6% | ||
| Liquidity | 41 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.31M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 65 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +5.0% |
|---|---|
| 1 month | +2.8% |
| 3 months | +9.3% |
| 6 months | +1.5% |
| 1 year | +2.4% |
| 3 years | +36.1% |
| 5 years | – |
Signals
| 50-day / 200-day average | 332.43 / 332.31 |
|---|---|
| Golden / death cross (60 days) | Golden, 48 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 12.05 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 20 Aug 2026 | USD 0.8000 |
| 21 May 2026 | USD 0.8000 |
| 27 Feb 2026 | USD 0.8000 |
| 13 Nov 2025 | USD 0.7900 |
| 14 Aug 2025 | USD 0.7900 |
| 15 May 2025 | USD 0.7900 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.